Edition:
United Kingdom

vTv Therapeutics Inc (VTVT.OQ)

VTVT.OQ on NASDAQ Stock Exchange Global Market

4.56USD
6:14pm GMT
Change (% chg)

$0.13 (+2.93%)
Prev Close
$4.43
Open
$4.47
Day's High
$4.63
Day's Low
$4.47
Volume
1,838
Avg. Vol
9,019
52-wk High
$8.04
52-wk Low
$3.63

Select another date:

Wed, Dec 6 2017

BRIEF-VTv Therapeutics Entered Into Agreement With MacAndrews & Forbes

* VTV THERAPEUTICS SAYS ON DEC 5, CO ENTERED INTO A LETTER AGREEMENT WITH MACANDREWS & FORBES GROUP LLC - SEC FILING

BRIEF-vTv Therapeutics reports Q3 GAAP loss per share of $0.38

* vTv Therapeutics reports third quarter 2017 financial and operational results

BRIEF-JDRF, VTV Therapeutics collaborate on Phase 2 study of novel treatment for type 1 diabetes

* JDRF and VTV Therapeutics announce collaboration on Phase 2 study of novel treatment for Type 1 diabetes

BRIEF-vTv Therapeutics announces issuance of U.S. patent

* Vtv therapeutics announces issuance of u.s. Patent covering methods of treatment using azeliragon Source text for Eikon: Further company coverage:

BRIEF-vTv Therapeutics Q2 loss per share $0.41

* vTv Therapeutics reports second quarter 2017 financial and operational results

Select another date: